grantDOI: https://doi.org/10.48105/pc.gr.151540 studyName: Preclinical Therapeutic Evaluation of ALY101 in a murine model of neurofibromatosis type 2 dataStatus: Data Pending initiative: Drug Discovery Initiative Registered Reports studyLeads: D. Wade Clapp studyStatus: Active diseaseFocus: Neurofibromatosis type 2 grantEndDate: 1685491200000 institutions: Indiana University fundingAgency: CTF manifestation: Schwannoma embargoEndDate: 1717113600000 grantStartDate: 1638316800000 relatedStudies: syn27261816 syn26383473 syn26238842 syn35632706 studyFileviewId: syn27261834 syn27261831 syn27261832 syn27261834 syn27261833
Drop files to upload
Preclinical Therapeutic Evaluation of ALY101 in a murine model of neurofibromatosis type 2 page is loading…